Navigation Links
eltrombopag in Medical News

Novel therapeutic approaches may improve patient outcomes in several platelet disorders

...l transfusions were the same in both arms. Oral eltrombopag for the Long-Term Treatment of Patients With Chron... multicenter, phase III study found that long-term eltrombopag therapy compared with placebo treatment significan...icroliters. They were randomized to receive either eltrombopag at a starting dose of 50 mg once daily (135 patien...

PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL

...ewed studies evaluating the safety and efficacy of eltrombopag in the short-term setting. Clinical data were presented and discussed that support eltrombopag increased platelet counts and reduced bleeding. ...ne Development Center at GSK. "An FDA approval for eltrombopag would represent an important development for these...

GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder

...s an increased risk of bruising and bleeding.(1,2) eltrombopag is an investigational, once-daily oral treatment t...it a Marketing Authorization Application (MAA) for eltrombopag in Europe in 2008. About the Data Submitted ...enna, Austria. At the end of the trial, 59% of eltrombopag treated patients on the 50mg dose and 16% of place...

Eltrombopag studied in Idiopathic Thrombocytopenic Purpura

...investigational oral platelet growth factor called eltrombopag successfully increased platelet counts and decreas...ind for ITP patients, the Phase 2 study found that eltrombopag doses of 50 and 75 mg daily elevated platelet coun... of adverse effects was similar in the placebo and eltrombopag treated groups. "These findings represent an im...

Drug May Help Reverse Clotting Deficiency

... eltrombopag might also aid patients with hepatitis liver disea... begin antiviral therapy for their condition after eltrombopag raised their platelet counts. "Eltrombopag is ...ly bleeding and bruising," Schwartz explained. eltrombopag is thought to stimulate megakaryocytes, the bone m...

GSK’s New Anticancer Drug A Huge Success In Drug trail

...y small, is likely to be transformed next year with the launch of Tykerb and other blockbuster drugs, such as the cervical cancer vaccine Cervarix and eltrombopag that is a blood-clotting agent in the treatment of breast cancer. They are also developing a lung cancer vaccine that would stop the disease from spre...
eltrombopag in Medical Technology

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

...fusions were the same in both arms. Oral eltrombopag for the Long-Term Treatment of Patients With Chron... multicenter, phase III study found that long-term eltrombopag therapy compared with placebo treatment significan...icroliters. They were randomized to receive either eltrombopag at a starting dose of 50 mg once daily (135 patien...

GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP

...hKline. GSK plans to submit a Marketing Authorization Application (MAA) for eltrombopag in Europe in 2008. Important Safety Information BOXED WARNI... to therapy with PROMACTA. Cataracts were observed in toxicology studies of eltrombopag in rodents. Perform a baseline ocular examination prior to administration o...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

... GSK plans to submit a Marketing Authorization Application (MAA) for eltrombopag in the treatment of chronic ITP in Europe in 2008; the proposed trade name ... to therapy with PROMACTA. Cataracts were observed in toxicology studies of eltrombopag in rodents. Perform a baseline ocular examination prior to administration o...

GSK Update on FDA Review of Promacta(R) (Eltrombopag)

...May 30, the Oncology Drugs Advisory Committee unanimously voted, 16-0, that eltrombopag demonstrated a favorable risk-benefit profile for the short-term treatment ...pivotal studies, the most common adverse events observed in patients taking eltrombopag were headache, common cold, and nausea. About GlaxoSmithKline GlaxoSmit...

FDA Grants Priority Review for PROMACTA(R) (eltrombopag)

...it a Marketing Authorization Application (MAA) for eltrombopag in the treatment of chronic ITP in Europe in 2008 ...se are rare.(1) About PROMACTA (eltrombopag) eltrombopag is an oral, non-peptide thrombopoietin receptor ag...ne marrow cells that give rise to blood platelets. eltrombopag was discovered as a result of research collaborati...

Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting

...iries: Frank Murdolo 215-751-7002 Tom Curry 215-751-5419 REFERENCES (1) Bussel, JB., Cheng, G., et al. Long-term safety and efficacy of oral eltrombopag for the treatment of subjects with idiopathic thrombocytopenic purpura (ITP): preliminary data from the EXTEND study. Blood. 2007; 110 (11). Published...

Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP

...189 patients across 135 centers in 26 countries. REPEAT (Repeat ExPosure to eltrombopag in Adults with Idiopathic Thrombocytopenic Purpura) will involve 50 patient...51 5419 REFERENCES (1) Bussel, J., Provan A., Shamsi T et al. eltrombopag Raises Platelet Count and Reduces Bleeding compared with Placebo ...
eltrombopag in Biological News

Lancet study supports new, highly effective treatment for blood disorder

...ed late 2007 in the New England Journal of Medicine. This trial showed that eltrombopag was effective in raising platelet counts and lowering bleeding in adult sub...cts. Ongoing and future studies will evaluate the safety and efficacy of eltrombopag as a long-term treatment for ITP, and its efficacy and safety in population...

Eltrombopag effective for hepatitis C patients with low blood-platelet counts

...the door to effective treatment. "In this study, eltrombopag increased platelet counts in a dose-dependent mann...common reason for a liver transplant. With other eltrombopag findings, NewYork-Presbyterian/Weill Cornell's Dr.... GlaxoSmithKline, which is developing eltrombopag. eltrombopag (marketed as Promacta in the U.S. and Revolade in ...
Other Tags
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 26, 2015 North American Seminars launches ... is dedicated to providing information regarding OT PT continuing ... community. As a leader in live hands ... over 200 live and online continuing education courses. ... Courses :, A Master Clinicians Approach to Advanced Concepts ...
(Date:3/26/2015)... 2015 Florida Hospital teamed up with ABC ... Health campaign and live Dr. Oz event, which took place ... More than a thousand people came out to see Dr. ... , The world renowned cardiothoracic surgeon and Emmy award winning ... and a panel of experts for the live health expo. ...
(Date:3/26/2015)... 2015 The Baruch S. Blumberg Institute ... nationally renowned scientists to focus exclusively on research to ... nearly triples its research capacity and has created the ... B and liver cancer in the United States. , ... Ju Tao Guo and Ying-Hsiu Su – and 16 ...
(Date:3/26/2015)... March 26, 2015 “The SWEET Act is ... healthy options more available and help parents who are working ... is a reasonable approach to support public health, and we ... issue for the health of all families,” said Dr. Jane ... Health on the introduction of the Sugar-Sweetened Beverage Tax (SWEET) ...
Breaking Medicine News(10 mins):Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
Other Contents